These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 26313695)
1. Assessment of Circulating MicroRNAs for the Diagnosis and Disease Activity Evaluation in Patients with Ulcerative Colitis by Using the Nanostring Technology. Polytarchou C; Oikonomopoulos A; Mahurkar S; Touroutoglou A; Koukos G; Hommes DW; Iliopoulos D Inflamm Bowel Dis; 2015 Nov; 21(11):2533-9. PubMed ID: 26313695 [TBL] [Abstract][Full Text] [Related]
2. Identification of Circulating MicroRNA Signatures in Crohn's Disease Using the Nanostring nCounter Technology. Oikonomopoulos A; Polytarchou C; Joshi S; Hommes DW; Iliopoulos D Inflamm Bowel Dis; 2016 Sep; 22(9):2063-9. PubMed ID: 27542126 [TBL] [Abstract][Full Text] [Related]
3. Circulating MicroRNA223 is a New Biomarker for Inflammatory Bowel Disease. Wang H; Zhang S; Yu Q; Yang G; Guo J; Li M; Zeng Z; He Y; Chen B; Chen M Medicine (Baltimore); 2016 Feb; 95(5):e2703. PubMed ID: 26844512 [TBL] [Abstract][Full Text] [Related]
5. Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis. Matusiewicz M; Neubauer K; Bednarz-Misa I; Gorska S; Krzystek-Korpacka M World J Gastroenterol; 2017 Jun; 23(22):4039-4046. PubMed ID: 28652656 [TBL] [Abstract][Full Text] [Related]
6. A microRNA signature in pediatric ulcerative colitis: deregulation of the miR-4284/CXCL5 pathway in the intestinal epithelium. Koukos G; Polytarchou C; Kaplan JL; Oikonomopoulos A; Ziring D; Hommes DW; Wahed R; Kokkotou E; Pothoulakis C; Winter HS; Iliopoulos D Inflamm Bowel Dis; 2015 May; 21(5):996-1005. PubMed ID: 25738378 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis. Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994 [TBL] [Abstract][Full Text] [Related]
8. Peripheral Blood miR-148 Serves as a Novel Biomarker in Ulcerative Colitis Patients. Ji Q; Li Y Clin Lab; 2020 Jun; 66(6):. PubMed ID: 32538061 [TBL] [Abstract][Full Text] [Related]
9. Novel MicroRNA Signature to Differentiate Ulcerative Colitis from Crohn Disease: A Genome-Wide Study Using Next Generation Sequencing. Lin J; Zhang X; Zhao Z; Welker NC; Li Y; Liu Y; Bronner MP Microrna; 2016; 5(3):222-229. PubMed ID: 27855604 [TBL] [Abstract][Full Text] [Related]
10. Alpha-1 antitrypsin and granulocyte colony-stimulating factor as serum biomarkers of disease severity in ulcerative colitis. Soendergaard C; Nielsen OH; Seidelin JB; Kvist PH; Bjerrum JT Inflamm Bowel Dis; 2015 May; 21(5):1077-88. PubMed ID: 25803506 [TBL] [Abstract][Full Text] [Related]
11. Plasma microRNA Profile Differentiates Crohn's Colitis From Ulcerative Colitis. Netz U; Carter J; Eichenberger MR; Feagins K; Galbraith NJ; Dryden GW; Pan J; Rai SN; Galandiuk S Inflamm Bowel Dis; 2017 Dec; 24(1):159-165. PubMed ID: 29272478 [TBL] [Abstract][Full Text] [Related]
12. Circulating microRNA146b-5p is superior to C-reactive protein as a novel biomarker for monitoring inflammatory bowel disease. Chen P; Li Y; Li L; Yu Q; Chao K; Zhou G; Qiu Y; Feng R; Huang S; He Y; Chen B; Chen M; Zeng Z; Zhang S Aliment Pharmacol Ther; 2019 Mar; 49(6):733-743. PubMed ID: 30734320 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of miR-595 and miR-1246 in the sera of patients with active forms of inflammatory bowel disease. Krissansen GW; Yang Y; McQueen FM; Leung E; Peek D; Chan YC; Print C; Dalbeth N; Williams M; Fraser AG Inflamm Bowel Dis; 2015 Mar; 21(3):520-30. PubMed ID: 25628040 [TBL] [Abstract][Full Text] [Related]
14. Integrated miRNA and mRNA expression profiling in inflamed colon of patients with ulcerative colitis. Van der Goten J; Vanhove W; Lemaire K; Van Lommel L; Machiels K; Wollants WJ; De Preter V; De Hertogh G; Ferrante M; Van Assche G; Rutgeerts P; Schuit F; Vermeire S; Arijs I PLoS One; 2014; 9(12):e116117. PubMed ID: 25546151 [TBL] [Abstract][Full Text] [Related]
15. Differential Expression of microRNAs in Peripheral Blood Mononuclear Cells Identifies Autophagy and TGF-Beta-Related Signatures Aberrantly Expressed in Inflammatory Bowel Disease. Mohammadi A; Kelly OB; Filice M; Kabakchiev B; Smith MI; Silverberg MS J Crohns Colitis; 2018 Apr; 12(5):568-581. PubMed ID: 29420705 [TBL] [Abstract][Full Text] [Related]
16. Site-Specific MicroRNA Expression May Lead to Different Subtypes in Ulcerative Colitis. Ranjha R; Aggarwal S; Bopanna S; Ahuja V; Paul J PLoS One; 2015; 10(11):e0142869. PubMed ID: 26569605 [TBL] [Abstract][Full Text] [Related]
17. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373 [TBL] [Abstract][Full Text] [Related]
19. Correlation of Blood and Intestinal Mucosa miR-34a Expressions with Disease Severity in Ulcerative Colitis Patients. Li YL; Cai CQ; Shi XL; Xu XF; Guo LJ Clin Lab; 2024 May; 70(5):. PubMed ID: 38747908 [TBL] [Abstract][Full Text] [Related]
20. A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease. Guo R; Fan G; Zhang J; Wu C; Du Y; Ye H; Li Z; Wang L; Zhang Z; Zhang L; Zhao Y; Lu Z J Alzheimers Dis; 2017; 60(4):1365-1377. PubMed ID: 29036818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]